nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Acute Leukemias XI Prognostic Factors and Treatment Strategies
|
|
|
2006 |
|
13 |
p. 1-11 |
artikel |
2 |
An epigenetic approach to the treatment of advanced MDS; the experience with the DNA demethylating agent 5-aza-2′-deoxycytidine (decitabine) in 177 patients
|
Wijermans, P. W. |
|
2005 |
|
13 |
p. 9-17 |
artikel |
3 |
Butyrates and decitabine cooperate to induce histone acetylation and granulocytic maturation of t(8;21) acute myeloid leukemia blasts
|
Gozzini, Antonella |
|
2005 |
|
13 |
p. 54-60 |
artikel |
4 |
Clinical experience with decitabine in North American patients with myelodysplastic syndrome
|
Yee, Karen W. L. |
|
2005 |
|
13 |
p. 18-24 |
artikel |
5 |
Clinical implications of aberrant DNA methylation patterns in acute myelogenous leukemia
|
Galm, Oliver |
|
2005 |
|
13 |
p. 39-46 |
artikel |
6 |
Decitabine activates specific caspases downstream of p73 in myeloid leukemia
|
Tamm, Ingo |
|
2005 |
|
13 |
p. 47-53 |
artikel |
7 |
Decitabine: a historical review of the development of an epigenetic drug
|
Vos, Dick de |
|
2005 |
|
13 |
p. 3-8 |
artikel |
8 |
Epigenetic therapy in MDS and acute AML: focus on decitabine
|
Lübbert, M. |
|
2005 |
|
13 |
p. 1-2 |
artikel |
9 |
In vivo effects of decitabine in myelodysplasia and acute myeloid leukemia: review of cytogenetic and molecular studies
|
Hackanson, Björn |
|
2005 |
|
13 |
p. 32-38 |
artikel |
10 |
Poster Session
|
|
|
2006 |
|
13 |
p. 12-27 |
artikel |
11 |
Quantification of outpatient management and hospitalization of patients with high-risk myelodysplastic syndrome treated with low-dose decitabine
|
Pitako, J. A. |
|
2005 |
|
13 |
p. 25-31 |
artikel |
12 |
Results of a phase 2 study of valproic acid alone or in combination with all-trans retinoic acid in 75 patients with myelodysplastic syndrome and relapsed or refractory acute myeloid leukemia
|
Kuendgen, Andrea |
|
2005 |
|
13 |
p. 61-66 |
artikel |
13 |
Satellite Symposia and Meet-the-Professor Sessions
|
|
|
2006 |
|
13 |
p. 28-126 |
artikel |
14 |
The hematopathological basis for studying effects of the demethylating agent 5-aza-2′-deoxycytidine (decitabine) in myelodysplasia
|
Schaefer, Hans Eckart |
|
2005 |
|
13 |
p. 67-79 |
artikel |